Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Asthma. New therapeutic approaches.

P J Barnes1

  • 1Department of Thoracic Medicine, National Heart and Lung Institute, London, UK.

British Medical Bulletin
|January 1, 1992
PubMed
Summary

New asthma therapies focus on improving current drugs and developing novel treatments. Research explores enhanced bronchodilators, anti-inflammatory agents, and immunomodulators for better asthma management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glucocorticoid resistance in asthma.

American journal of respiratory and critical care medicine·1995
Same author

Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma.

The Journal of experimental medicine·1995
Same author

Inhibition of macrophage inflammatory protein-1 alpha expression by IL-10. Differential sensitivities in human blood monocytes and alveolar macrophages.

Journal of immunology (Baltimore, Md. : 1950)·1995
Same author

Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.

Molecular pharmacology·1995
Same author

Corticosteroid inhibition of macrophage inflammatory protein-1 alpha in human monocytes and alveolar macrophages.

The American journal of physiology·1995
Same author

Cytokine expression in normal, atopic, and asthmatic subjects using the combination of sputum induction and the polymerase chain reaction.

Thorax·1995

Area of Science:

  • Pulmonology
  • Pharmacology
  • Immunology

Background:

  • Asthma treatment has seen no new drug classes in 20 years.
  • Existing therapies include bronchodilators and corticosteroids.
  • Novel drug development is crucial for improved asthma management.

Purpose of the Study:

  • To review current and emerging therapeutic strategies for asthma.
  • To highlight advancements in bronchodilators, anti-inflammatory drugs, and immunomodulators.
  • To discuss the future prospects of asthma drug development.

Main Methods:

  • Literature review of recent advancements in asthma pharmacotherapy.
  • Analysis of novel drug classes and improvements in existing treatments.
  • Exploration of therapeutic targets including cytokines and immune pathways.

Main Results:

  • Improvements in bronchodilators include long-acting beta 2-agonists and M3-selective anticholinergics.
  • Novel bronchodilators like K+ channel activators and phosphodiesterase inhibitors are under development.
  • Research is focused on developing potent inhaled corticosteroids with fewer side effects and cytokine-targeting therapies.
  • Leukotriene D4-antagonists and immunomodulatory drugs show promise for severe or specific immune-related asthma.

Conclusions:

  • Current research aims to enhance existing asthma medications and introduce novel therapeutic classes.
  • Targeting cytokines and immune pathways offers promising avenues for future asthma treatments.
  • While a cure remains distant, the ideal asthma drug would offer convenient, side-effect-free oral administration.

Related Experiment Videos